Zai Lab Limited
Zai Lab Limited (ZLAB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ZLAB · as of Jun 8, 2026
Key Statistics
Explore Zai Lab Limited Data
zlab stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 81.8%
The ZLAB analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $35.00, representing +112.38% upside from the current price of $16.48.
Competitors & Peers
zlab competitorsZLAB
AAPG
APGE
CDTX
CNTA
IDYAAbout Zai Lab Limited
Zai Lab Limited Operating primarily in Mainland China and Hong Kong, Zai Lab Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medical treatments. Their…
what is zai lab limited · zlab stock overview · zai lab limited company profile · who is zai lab limited ceo · zlab NASDAQ · zai lab limited headquarters · zai lab limited business segments
About Stock Overview & Key Data
Zai Lab Limited (ZLAB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 20, 2017. As of the latest trading session, ZLAB stock price is $16.48, with a market capitalization of $1.9B. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Zai Lab Limited (ZLAB) stock price is $16.48. The stock is traded on NASDAQ under the ticker symbol ZLAB. The 52-week range is $15.96 – $44.34.